How Gilead Lost $7.8B in October Alone Post author:Sam Post published:November 2, 2017 Post category:BioPharma Gilead Sciences’ third-quarter financial results were dismal, to say the least. Source: BioSpace You Might Also Like JSR Life Sciences Snaps Up CRO in $400M Deal December 19, 2017 Merck & Co. Scraps Experimental Cholesterol Drug Anacetrapib October 11, 2017 Novartis AG Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year February 28, 2017
